XHS
State Street SPDR S&P Health Care Services ETF
SPDR S&P Health Care Services ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Health Care Services Select Industry Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 136.2 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Sep 28, 2011 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| LIFESTANCE HEALTH GROUP, INC. | 2.1 % |
| GENEDX HOLDINGS CORP. CLASS A | 2.1 % |
| HINGE HEALTH INC-A | 2.1 % |
| NEOGENOMICS INC | 2.0 % |
| HIMS & HERS HEALTH, INC. CLASS A | 2.0 % |
| PACS GROUP INC | 2.0 % |
| BROOKDALE SENIOR LIVING INC | 2.0 % |
| MOLINA HEALTHCARE INC | 1.9 % |
| APOLLO MEDICAL HOLDINGS, INC. | 1.9 % |
| TENET HEALTHCARE CORP | 1.9 % |
Constituent Breakdown
| Number of holdings | 59 |
| Herfindahl-Hirschman Index | 194 |
| Wgt avg mkt cap (mns) | $22,977 |
| Large cap (>$10bn) | 36.1% |
| Mid cap ($2-10bn) | 35.3% |
| Small cap (<$2bn) | 26.5% |
| Developed mkts. | 98.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 96.9 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 7.2% | 17.6% | 11.6% | 9.9% | 0.3% | 7.2% | -- | 11.0% |
| Dividend Yield | 0.0% | 0.3% | 0.4% | 0.3% | 0.3% | 0.5% | -- | 0.9% |
| Total Returns | 7.2% | 17.9% | 11.9% | 10.2% | 0.6% | 7.7% | -- | 11.9% | Ann. Volatility | 17.8% | 17.6% | 18.6% | 17.9% | 21.1% | 22.4% | -- | 21.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.69 | 21% |
| MSCI EAFE | 0.46 | 16% |
| MSCI Emg Mkts | 0.27 | 9% |
Liquidity Measures
| Avg. volume (000) | 17 |
| ADV traded (mns) | $2 |
| Turnover | 1.6% |
| Avg. Bid/Ask (% of price) | 0.25% |
Technical Indicators
| 30d moving avg. (EMA) | $119.10 |
| Relative strength (RSI) | 77 |
| MACD/Signal | 3.79/3.04 |
| Bollinger Bands (Upper/Lower) | $129.67/$110.90 |
| Short interest (% of AUM) | 19.4% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XHS |
Expenses vs. XHS |
ALTAR Score™ vs. XHS |
|---|---|---|---|---|
| IHF | iShares U.S. Healthcare Providers ETF | 42.9% | +5 bp | +3.2% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 27.4% | +5 bp | +3.0% |
| FXH | First Trust Health Care AlphaDEX Fund | 26.0% | +27 bp | +1.5% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 22.2% | -6 bp | -1.3% |
| SRHQ | SRH U.S. Quality ETF | 15.2% | 0 bp | +3.1% |
| VHT | Vanguard Health Care ETF | 15.1% | -26 bp | +1.6% |
| FHLC | Fidelity MSCI Health Care Index ETF | 15.1% | -27 bp | +1.8% |
| RWL | Invesco S&P 500 Revenue ETF | 14.8% | +4 bp | +2.6% |
| YUNG | Corgi Longevity Consumer ETF | 14.5% | 0 bp | -0.3% |
| RPV | Invesco S&P 500 Pure Value ETF | 14.4% | 0 bp | +5.2% |
Risk and Returns: XHS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/29/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.7%
ALTAR SCORE™
21st
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,399 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. XHS's ALTAR Score™ is approximately -0.8 standard
deviations above the category average. This places XHS in the 21st percentile
among funds in the category.
Sell-Side Consensus
$137.14
PRICE TARGET
+4.7%
UPSIDE